Latest News & Updates
Breaking News
23 hours ago
Vaibhavi M.
Other trending news you may like to read
Verrica Pharmaceuticals Achieves First U.S. Patient Dosing in COVE-3 Phase 3 Trial for Common Warts
Verrica Pharmaceuticals doses first U.S. patient in COVE-3, the second pivotal Phase 3 study for YCANTH in common warts, alongside a parallel Japanese enrollment.
Vaibhavi M.
FibroBiologics Secures U.S. Patent Allowance for 3D Spheroid Fibroblast Wound Therapy Covering CYWC628 Program
FibroBiologics receives USPTO Notice of Allowance for 19 claims covering 3D spheroid fibroblast wound therapy, directly aligned with its CYWC628 Phase 1/2 trial.
Vaibhavi M.
Achieve Life Sciences Receives CRL for Cytisinicline NDA After Third-Party CMO Receives OAI Classification
Achieve Life Sciences' cytisinicline NDA blocked by CMO OAI classification, not clinical data. Resubmission targeting Q4 2026 with new manufacturer Adare.
Vaibhavi M.
Sun Pharma Acquires Innovcare Lifesciences in Rs. 271.2 Crore Deal to Expand India Manufacturing Footprint
Sun Pharma acquires Innovcare Lifesciences for Rs. 271.2 crore, adding nutraceutical and cosmeceutical manufacturing to its India GMP footprint.
Vaibhavi M.
